-
Loading metrics
A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol
- Tomoya Kurokawa,
- Tomohisa Iinuma,
- Haruna Ebisu,
- Tomoha Yanagidaira,
- Yosuke Inaba,
- Tadami Fujiwara,
- Yoko Hattori,
- Tominaga Fukazawa,
- Takahiro Aoki,
- Haruhiko Koseki
x
- Published: February 26, 2026
- https://doi.org/10.1371/journal.pone.0342387